Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AtaCor Medical, Inc. logo — The heart is a wonderful thing... to leave untouched.

AtaCor Medical, Inc.

The heart is a wonderful thing... to leave untouched.

Founded 2014 United States San Clemente, United States 25 employees Series C Total: $62.00M Health Care, Medical Devices

General Information

Company Name AtaCor Medical, Inc.
Founded Year 2014
Location United States San Clemente, United States +1
Employees 25
Industries Health Care, Medical Devices
Funding Stage Series C
Social

Get notified when AtaCor Medical, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AtaCor Medical, Inc.

AtaCor Medical, Inc. is a cutting-edge health care startup based in the United States, founded in 2014. The company's slogan, "The heart is a wonderful thing... to leave untouched," encapsulates its vision of transforming cardiac rhythm management. AtaCor Medical is developing an innovative solution, the AtaCor EV Temporary Pacing Lead System, which aims to revolutionize temporary cardiac pacing. This system promises reliable, prompt, imaging-free temporary pacing with safe post-procedure ambulation, while eliminating the complications associated with transvenous leads and the patient discomfort of transcutaneous pacing. The company recently secured a remarkable $28.00M Series C investment on 24 April 2024, with significant participation from investors including Arboretum Ventures, Hatteras Venture Partners, Longview Ventures, CHV, and baymed venture partners. This substantial investment underscores the industry's confidence in AtaCor Medical, Inc. and its innovative approach to cardiac rhythm management. Although the AtaCor EV Temporary Pacing System is still under development and not yet approved for sale, the company's focused vision and strong investor backing position it as a promising player in the evolving landscape of cardiac care technology.

Taxonomy: medical device, cardiac rhythm management, temporary pacing, cardiology, electrophysiology, cardiac pacing, AtaCor Medical Inc., extracardiac, extravascular

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor Investor Investor
•••• •••• 		24 Apr 2024
Series B •••••• 5
Investor Investor Investor Investor Investor
28 Apr 2020
Series A •••••• - 18 Sep 2018
Seed Round •••••• - 12 Jun 2018

AtaCor Medical, Inc. Alternatives & Competitors

AtaCor Medical, Inc. vs
SwiftSync
SwiftSync

Pioneering the future of cardiac care with innovative dual-chamber pacing technology.

Seed
Health Care, Medical Devices
Compare AtaCor Medical, Inc. vs SwiftSync
AtaCor Medical, Inc. vs
Electroducer
Electroducer France

A device to secure and optimise Trans-Heart Valve Interventions (THV) or Percutaneous Coronary Inte...

Series A
10 employees
Medical Devices
Compare AtaCor Medical, Inc. vs Electroducer
AtaCor Medical, Inc. vs
EBR Systems, Inc.
EBR Systems, Inc. United States

Overcoming the limitations of conventional CRT through Wireless, LV Endocardial Pacing

Private Equity
89 employees
Biotechnology, Health Care
Compare AtaCor Medical, Inc. vs EBR Systems, Inc.

FAQ About AtaCor Medical, Inc.

The heart is a wonderful thing... to leave untouched.
AtaCor Medical, Inc. was founded in 2014.
AtaCor Medical, Inc. is headquartered in San Clemente, United States.
AtaCor Medical, Inc. operates in the following industries: Health Care, Medical Devices.
AtaCor Medical, Inc. has approximately 25 employees.
AtaCor Medical, Inc. has completed 4 funding rounds, raising a total of $62.00M. The latest funding stage is Series C.
Top alternatives and competitors to AtaCor Medical, Inc. include SwiftSync, Electroducer, EBR Systems, Inc., Pacertool AS, Heart Rhythm Society. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AtaCor Medical, Inc. and SwiftSync are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AtaCor Medical, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes